Point72 Asia (Singapore)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,463
Closed -$160K 912
2024
Q4
$160K Sell
7,463
-2,801
-27% -$68.1K 0.04% 275
2024
Q3
$320K Buy
+10,264
New +$255K 0.06% 259
2024
Q1
Sell
-3,811
Closed -$45.7K 1075
2023
Q4
$45.7K Buy
+3,811
New +$31.2K 0.01% 324

Other funds holding CDNA

Point72 Asia (Singapore)'s CDNA Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of CareDx (CDNA) in Q1 2025, closing a stake of 7,463 shares — an estimated $160K sold.

Point72 Asia (Singapore) first reported a position in CDNA in Q4 2023 and held it in 3 quarters. The position peaked at $320K in Q3 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 7,463 CareDx shares in Q1 2025, an estimated $160K.
  • Point72 Asia (Singapore) first reported a position in CareDx in Q4 2023 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s CareDx position peaked at $320K in Q3 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.